Alaunos Therapeutics Completes Concurrent Equity Financings Totaling US$2.9 Million

Marco Zingaro North America Legal Chronicle
Tagged:

Norton Rose Fulbright has advised Alaunos Therapeutics.Alaunos Therapeutics has completed two concurrent financings, including a Registered Direct Offering and a private placement of A-2 convertible preferred…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here